https://drug-dev.com/dosing-completed-in-115-participant-bioavailability-bioequivalence-clinical-trial-for-proprietary-sleep-apnea-drug-candidate/
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint